Navigation Links
Novartis Class Awarded $250 Million in Punitive Damages
Date:5/19/2010

n">Grant Morris, of Washington, D.C. 

"This is a just award, and one richly deserved by Novartis' female sales reps. The 5,600 women in the class endured egregious gender discrimination for years. All the while, the company did nothing, even after being warned time after time about the deep-seated culture of discrimination at the company," said Mr. Sanford. "What the jury did here today was the right thing—not only for the women in the class but also for working women around the country who deserve to work in an environment free of discrimination."

"The jury's decision speaks to Novartis with a force far greater than any single voice.  For the thousands of women across the country who suffered discrimination, finally the time has come that Novartis must hear and recognize the depth of its injustice," said Katherine Kimpel. "Corporations cannot violate our federal equal employment laws and get away with it. Jurors like the ones who ruled today will not stand for it. If you profit off of the American people, you have to abide by our civil rights laws."  

Although several of Novartis' witnesses claimed during the trial that the company had a "zero tolerance policy" for discrimination, those witnesses each admitted that the company's managers were never terminated or demoted, even when complaints of discrimination were substantiated by its own HR department.

Steven Wittels said of today's victory, "All of the brave women who testified have played a role in standing up to this company's discriminatory treatment of women, and we are gratified to have been able to help them in this quest.  We all hope that no female employee in Novartis or any other large corporation will ever have to endure what these women endured while
'/>"/>

SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 2017
3. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
4. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
5. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
6. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
7. Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
8. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
9. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
10. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
11. Heptares Therapeutics Announces Agreement With Novartis Option Fund to Apply its StaR(TM) Technology and Generate Novel Drug Leads Against a GPCR Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 James Sherley says he ... adult tissue stem cell technology since his days as a ... Philadelphia in the late 1990’s. Sherley founded the ASCTC ... company holds all the intellectual property developed in Sherley’s research ... the Massachusetts Institute of Technology (MIT), and more recently as ...
(Date:10/30/2014)... Khaimah, UAE (PRWEB) October 30, 2014 Grace ... of Dr. James A. Manganello, Chairman of the Board, to ... The Bahamas. The appointment was made by the Ministry ... on September 24th, 2014. , More than a ... and Research Bill , Prime Minister Perry Christie said the ...
(Date:10/30/2014)... in the development of quantum technologies has been proposed ... published today (28 October) in Nature Communications , ... a new type of flexibly designed microscopic trap for ... and specialised superfast computers, often depend on harnessing the ... these tiny particles are hugely problematic because of the ...
(Date:10/27/2014)... , October 27, 2014 ... right to produce, exhibit and sell its artificial ... to impeach their patent.      (Photo: ... four years of fighting, the definitive judgement has ... and produces innovative and accessible hi-tech prostheses with ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2
... PharmaNet Development Group, Inc., a leading provider of clinical development services to ... participation at several international professional meetings during the month of June. ... Drug Information Association (DIA) Annual Meeting, ... ...
... ... The use of codon optimization in gene synthesis has long been ... been awarded two US patents covering the technology. DNA2.0,s approach goes beyond ... gene optimization. The algorithm associated with this patent has been proven to ...
... the momentum of their previous events, the Stem Cell ... Stem Cell Awareness Rally in Denver, Colorado on June ... Florida, drew past and prospective patients, news media, U.S. ... public interested in learning more about stem cell treatment. ...
Cached Biology Technology:PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 3Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 2Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 3
(Date:10/28/2014)... Europe and China have published a paper in the ... that reveals important details about key transitions in the ... and exotic algae, mosses, ferns, trees and flowers growing ... we eat and the ornamental plants adorning our homes, ... years of history., "Our study generated DNA sequences from ...
(Date:10/28/2014)... moving activity in a novel environment are linked ... to an experimental study completed at the University ... Fisheries Research Institute. The study used novel, long-term ... angling trials to analyse if behaviours predict the ... traditional and enriched hatchery rearing environments. Based ...
(Date:10/27/2014)... have delivered a scientific one-two punch with a pair ... via their sticky ends. , Collagen is the most ... and the fibrous tissues that support cells and hold ... synthetic collagen for tissue engineering and cosmetic and reconstructive ... been studying synthetic collagen for a decade, teasing out ...
Breaking Biology News(10 mins):New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3Fish 'personality' linked to vulnerability to angling 2'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3
... the subtext of a novel, the human genome sequence ... of A, C, T and G. Since DNA is ... genome sequences among individuals also holds clues to ancestry. ... sequence variations to diseases are very common nowadays. But ...
... - Discovery that a specific gene is integral to both ... toxin in the kernels may lead to ways to control ... the fungal gene ZFR1 and found that it is vital ... Production of the toxin decreased when the scientists disabled the ...
... 2008 -- Exposure to levels of radon gas typically found ... risk of developing lung cancer by as much as 60 ... issue of the journal Health Physics. The finding differs significantly ... of low-level radon exposure, which have detected a slightly elevated ...
Cached Biology News:Multi-institutional study identifies new form of inherited risk of cancer 2Defining gene's role may lead to prevention of dangerous corn toxin 2Defining gene's role may lead to prevention of dangerous corn toxin 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 2Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 4
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
...
Bovine Serum...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
Biology Products: